<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03158376</url>
  </required_header>
  <id_info>
    <org_study_id>2014_12</org_study_id>
    <secondary_id>2014-005226-35</secondary_id>
    <nct_id>NCT03158376</nct_id>
  </id_info>
  <brief_title>Preoperative Gabapentin for Chronic Pain After Thoracotomy (GABATHOMIE).</brief_title>
  <acronym>GABATHOMIE</acronym>
  <official_title>Perioperative Gabapentin for Chronic Post-thoracotomy Pain: a Randomized, Double Blind, Placebo-controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Lille Nord de France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the effects of prolonged preoperative gabapentin treatment (10 days) on chronic
      pain after thoracotomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized, double blind study enrolling 200 adults undergoing thoracotomy. Patients receive
      either 75 mg hydroxyzine before surgery and placebo 3 times daily for 10 days or 1200 mg
      gabapentin before surgery continued for 10 days. All patients receive also a thoracic
      epidural analgesia.

      Assessment of chronic pain at 3 month with an evaluation by a physician (pain intensity, pain
      quality and analgesia requirement).

      Assessment of acute pain in the early postoperative period (pain intensity, pain quality and
      analgesia requirement).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Persistent chronic post-thoracotomy pain</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>Pain intensity is measured on a 11-point numeric pain rating scale ; a score &gt;=0 is considered as chronic pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantitative pain assessment: Acute postoperative pain intensity</measure>
    <time_frame>Within the first 10 postoperative days</time_frame>
    <description>Measured on a 11-point numeric rating scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative pain assessment: Rescue analgesics requirement</measure>
    <time_frame>Within the first 3 months after surgery</time_frame>
    <description>consumption of additional analgesics (opioids, nefopam or non steroidal anti-inflammatory drug) and time to first request.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative pain assessment: volume of epidural infusion</measure>
    <time_frame>Within the 5 postoperative days</time_frame>
    <description>total dose of epidural local anesthetic and epidural morphine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Qualitative pain assessment: incidence of neuropathic pain</measure>
    <time_frame>postoperative day 2</time_frame>
    <description>Assessed by DN4 (Neuropathic pain 4), NPSI (Neuropathic Pain Symptom Inventory) and QDSA ( Saint Antoine French questionnaire = McGill questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Qualitative pain assessment: incidence of neuropathic pain</measure>
    <time_frame>postoperative day 6</time_frame>
    <description>Assessed by DN4 (Neuropathic pain 4), NPSI (Neuropathic Pain Symptom Inventory) and QDSA ( Saint Antoine French questionnaire = McGill questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Qualitative pain assessment: incidence of neuropathic pain</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>Assessed by DN4 (Neuropathic pain 4), NPSI (Neuropathic Pain Symptom Inventory) and QDSA ( Saint Antoine French questionnaire = McGill questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Qualitative pain assessment: Rescue analgesics requirement for neuropathic pain</measure>
    <time_frame>within the first 3 months after surgery</time_frame>
    <description>Time to first request and consumption (doses and length of treatment) of gapapentinoids, amitriptyline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Qualitative pain assessment: Objective assessment of hyperalgesia by the Von Frey filaments test</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>60 and 300 g Von Frey filaments test on the thoracotomy area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heath related quality of life</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>measured by EQ-5D-5L questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of sedation in the operating room</measure>
    <time_frame>baseline</time_frame>
    <description>measured by MOAA/S scale ( Modified Observer's Assessment of alternes/sedation Scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">238</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>gabapentin group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the day before surgery : gabapentin 400 mg orally
preoperatively (2 hours before surgery) : 3 capsules each containing 400 mg gabapentin (total gabapentin dose 1200 mg) and intravenous infusion of 50 ml of normal saline solution
postoperative day 1 to 10 : 400 mg x 3 ( gabapentin 1200 mg daily)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The day before surgery: 1 placebo capsule orally
preoperatively (2 hours before surgery) : 3 placebo capsules and intravenous infusion of 75 mg hydroxyzine
postoperative day 1 to 10: 1 placebo capsule x 3</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <arm_group_label>gabapentin group</arm_group_label>
    <other_name>gabapentin Biogaran 400 mg capsule</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>placebo group</arm_group_label>
    <other_name>placebo oral capsule (lactose)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years

          -  elective lung resection via thoracotomy

        Exclusion Criteria:

          -  extended pleurectomy and chest wall resection

          -  previous ipsilateral thoracotomy

          -  previous ipsilateral radiotherapy

          -  thoracotomy for pyothorax

          -  chest injury

          -  palliative surgery

          -  contraindicated placement of a thoracic epidural catheter

          -  allergy to medications on protocol

          -  pre-existing pain syndrome

          -  current treatment with morphine, gabapentin, pregabalin, anticonvulsivants or
             tricyclic antidepressants

          -  a history of past or current drug addiction

          -  severe hepatic, renal or cardiovascular disorders

          -  inability to understand the study protocol or to answer the questionnaires on pain and
             quality of life

          -  severe psychiatric disorders

          -  incompetent adults under some form of guardianship

          -  refusal of the protocol

          -  persons without social security coverage

          -  pregnant or lactating woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacques Desbordes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lille University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jacques Desbordes, MD</last_name>
    <email>jacques.desbordes@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Thoracic Surgery, Lille University Hospital</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabrina Habchi, MD</last_name>
      <email>habchi.s@hotmail.fr</email>
    </contact>
    <investigator>
      <last_name>Sabrina HABCHI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacques DESBORDES, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delphine DEBLAUWE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine DUSSON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Michel WATTIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuel ROBIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dobrin BOGDAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mouhamed MOUSSA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caroline BRANDT, PA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2017</study_first_submitted>
  <study_first_submitted_qc>May 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2017</study_first_posted>
  <last_update_submitted>April 23, 2018</last_update_submitted>
  <last_update_submitted_qc>April 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>gabapentin</keyword>
  <keyword>thoracotomy</keyword>
  <keyword>chronic post-thoracotomy pain</keyword>
  <keyword>acute post-thoracotomy pain</keyword>
  <keyword>quality of life</keyword>
  <keyword>neuropathic pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

